| Albert Thad Gros, MD | |
|
4007 James Casey, A250, Austin, TX 78745 | |
| (512) 441-9796 | |
| (512) 441-8448 |
| Full Name | Albert Thad Gros |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 4007 James Casey, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144383555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | E6387 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Albert Thad Gros, MD 4007 James Casey, A250, Austin, TX 78745 Ph: (512) 441-9796 | Albert Thad Gros, MD 4007 James Casey, A250, Austin, TX 78745 Ph: (512) 441-9796 |
News Archive
Severe cases of COVID-19 can now be detected at an early stage. Researchers at the University of Zurich have identified the first biomarker that can reliably predict which patients will develop severe symptoms.
In an Australian first, leading experts and organizations have agreed a position statement on screening for ovarian cancer, Australia's leading cause of death from gynecological malignancy.
A collaboration of French and Canadian researchers have found that sucking a portion of a spherical globule of cells into a tiny pipette provides information about the adhesion between cells and the elastic properties of the tissue. The method is a novel approach for the study of the structural properties of tissues, and should offer insights into processes such as embryonic development, tissue growth and cancer. A paper describing the research appears online in Physical Review Letters on May 24.
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS®, a treatment for hypertension.
A new article by infection control expert William Jarvis, M.D., President, Jason and Jarvis Associates, LLC, highlights the importance of patient safety features in the design of IV needleless connectors.
› Verified 9 days ago
Dr. Chris C Hart, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9805 Brodie Ln, Austin, TX 78748 Phone: 512-462-1936 Fax: 512-394-9388 | |
Dr. Robert C Johnston, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12200 Renfert Way Ste G-3, Austin, TX 78758 Phone: 512-821-2540 Fax: 512-973-3533 | |
Dr. Keikhosrow M Kavoussi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4303 James Casey St, Suite A, Austin, TX 78745 Phone: 512-444-1414 Fax: 512-444-5621 | |
Dr. Andrea L. Campaigne, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12201 Renfert Way Ste 250, Austin, TX 78758 Phone: 512-994-2662 Fax: 512-406-6202 | |
Jonathan Edmond Pepper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6611 River Place Blvd Ste 202, Austin, TX 78730 Phone: 512-473-8300 | |
Akua Tiwaa Afriyie-gray, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 303, Austin, TX 78723 Phone: 512-324-0970 | |
Mr. Sasan Askari, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4007 James Casey St, Suite A-250, Austin, TX 78745 Phone: 512-444-2111 Fax: 512-444-2114 |